Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Molecular Templates Inc (MTEM)

Molecular Templates Inc (MTEM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 461,743
  • Shares Outstanding, K 36,969
  • Annual Sales, $ 13,290 K
  • Annual Income, $ -30,290 K
  • 60-Month Beta 3.16
  • Price/Sales 34.06
  • Price/Cash Flow N/A
  • Price/Book 8.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.32
  • Number of Estimates 1
  • High Estimate -0.32
  • Low Estimate -0.32
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -77.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.80 +65.88%
on 11/14/19
14.05 -19.72%
on 11/29/19
+2.12 (+23.14%)
since 11/08/19
3-Month
5.31 +112.28%
on 09/11/19
14.05 -19.72%
on 11/29/19
+5.78 (+105.09%)
since 09/10/19
52-Week
3.19 +253.61%
on 12/24/18
14.05 -19.72%
on 11/29/19
+6.94 (+159.91%)
since 12/10/18

Most Recent Stories

More News
Molecular Templates Announces Presentations at the American Society of Hematology (ASH) 2019 Annual Meeting

Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 11.28 (-9.69%)
Molecular Templates to Present at Two December Investor Conferences

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 11.28 (-9.69%)
Molecular Templates, Inc. Announces Pricing of $50.0 Million Public Equity Offering

Molecular Templates, Inc. (Nasdaq: MTEM) (the "Company" or "Molecular"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary engineered toxin...

MTEM : 11.28 (-9.69%)
Molecular Templates, Inc. Announces Proposed Public Equity Offering

Molecular Templates, Inc. (Nasdaq: MTEM) (the "Company" or "Molecular"), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company's proprietary engineered toxin...

MTEM : 11.28 (-9.69%)
Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

-Molecular Templates to receive $38 million upfront payment, including equity investment, with potential for additional milestone and royalty payments on future sales-

MTEM : 11.28 (-9.69%)
VRTX : 220.27 (+0.41%)
Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111

Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrolment of the first patient in a Phase I study with its partner Molecular Templates (Nasdaq:...

MTEM : 11.28 (-9.69%)
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular," "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company's proprietary...

MTEM : 11.28 (-9.69%)
Molecular Templates Hosting Analyst & Investor Meeting

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 11.28 (-9.69%)
Molecular Templates to Present at the Ladenburg Thalmann and Cantor Fitzgerald Healthcare Conferences

Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the company's proprietary engineered toxin bodies (ETBs), which are differentiated,...

MTEM : 11.28 (-9.69%)
Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results

Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular," "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company's proprietary...

MTEM : 11.28 (-9.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MTEM with:

Business Summary

Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered...

See More

Key Turning Points

2nd Resistance Point 13.53
1st Resistance Point 12.40
Last Price 11.28
1st Support Level 10.67
2nd Support Level 10.06

See More

52-Week High 14.05
Last Price 11.28
Fibonacci 61.8% 9.90
Fibonacci 50% 8.62
Fibonacci 38.2% 7.34
52-Week Low 3.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar